Table 2.

Characteristics of Staphylococcus aureus in HIV patients and healthy controls, Gabon.

		S. aureus, n (%)		OR (95%CI)	P
		HIV positive participants (n = 56)	Healthy controls (n = 69)
Antimicrobial resistance	Penicillin	52 (92.9%)	66 (95.7%)	0.6 (0.1–3.7)	0.5
	Oxacillin	3 (5.4%)	2 (2.9%)	1.9 (0.2–23.4)	0.7
	Erythromycin	4 (7.1%)	10 (14.5%)	0.5 (0.1–1.7)	0.3
	Gentamicin	1 (1.8%)	1 (1.5%)	1.2 (0.0–98.4)	1
	Tetracyclin	26 (46.4%)	30 (43.5%)	1.1 (0.5–2.4)	0.7
	Cotrimoxazole	32 (57.1%)	33 (47.8%)	1.4 (0.7–3.3)	0.3
Virulence factors	lukS-PV/lukF -PV (PVL)	24 (42.9%)	16 (23.2%)	2.5 (1.1–5.9)	0.02
	sea	18 (32.1%)	17 (24.6%)	1.5 (0.6–3.5)	0.4
	seg	15 (26.8%)	22 (31.9%)	0.8 (0.3–1.8)	0.5
	sec	6 (10.7%)	6 (8.7%)	1.3 (0.3–5)	0.7
	eta	2 (3.6%)	1 (1.5%)	2.5 (0.1–100)	0.6
	tst	3 (5.4%)	3 (4.4%)	1.3 (10)	1